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Abstract
Shiga toxin producing Escherichia coli (STEC) are the most virulent diarrhoeagenic E. coli known to date. They can spread 
with alarming ease via the food chain, as recently demonstrated by the large outbreak of STEC O104:H4 borne by sprouted 
seeds in 2011, clustered in northern Germany, and subsequently affecting other countries. Indeed, a significant number of 
infections to verocytotoxin producing Escherichia coli O104:H4 have been reported from the WHO European Region resulting 
in many cases of bloody diarrhoea and haemolytic uraemic syndrome in Germany, 15 other European countries and North 
America. Eventually, the European Food Standards Agency, (EFSA), identified the likely source to a single consignment of 
fenugreek seeds from an Egyptian exporter as being linked to the two outbreaks in Germany and France. The situation 
was closely monitored by the Chief Sanitary Inspectorate public health authority in Poland where actions undertaken 
ensured that the public was well informed about the dangers of STEC contamination of food, how to avoid infection, and 
what to do if infected. Tracing the fenugreek distributors also enabled the identification of suspected batches and their 
isolation. As a result, there were very few reported cases of STEC infection in Poland. Effective control over such outbreaks 
is therefore a vital public health task. This should include early detection and rapid identification of the contagion mode, 
followed by removing the foodstuff(s) from the market, providing consumer advice, and preventing secondary spreading. 
As a mitigation measure, screening/monitoring those involved in food handling is also warranted to exclude carriers who 
can be asymptomatic.
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ChArACteristiCs of enterohAemorrhAgiC 
EschErichia coli (eheC) strAins
E. coli bacteria are found normally in gut flora of the lower 
intestines in animals or humans and are usually transmitted 
via the faecal/oral route. Most strains are harmless 
commensals, but some are pathogenic to humans and these 
can be divided into different groups: enteropathogenic E. coli 
(EPEC) – associated with infantile diarrhoea, enteroinvasive 
E. coli (EIEC) – cause dysentery-like illnesses, enterotoxigenic 
E. coli (ETEC) – produce enterotoxins causing diarrhea, 
enteroaggregative E. coli (EAEC) – express aggregative 
adherence, diffusely adherent E. coli (DAEC) – adhere to 
the surface of epithelial cells, enterohaemorrhagic E. coli 
(EHEC) – produce Verocytotoxin or Shiga-like toxin, (Vtx, 
Stx), which is frequently identified as a causative agent of 
life-threatening diseases in humans such as haemorrhagic 
colitis (HC) and haemolytic-uraemic syndrome (HUS) [1, 2].
The primary sources of pathogenic E. coli contaminating 
foods are human shedders which constitute the primary 
reservoir for pathogenic E. coli belonging to the first of the 
aforementioned groups. The EHEC strains, however, can 
cause severe food-borne disease where the primary reservoirs 
are domestic ruminants, especially cattle, sheep and goats; 
these farmed ruminants being healthy EHEC carriers [2]. 
As a zoonotic pathogen, EHEC can be transmitted from 
animals to humans through direct contact with animals, 
but more often through consumption of undercooked 
meat, unpasteurized dairy products and vegetables, or 
water contaminated by the faeces of carriers. Person-to-
person transmission has also been documented [1, 3, 4]. 
EHEC is known to produce characteristic toxins similar 
to those produced by Shigella dysenteriae and are known 
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as Vtx or Stx, as defined earlier. Typical EHEC strains 
produce Stx but also encode a LEE, (locus of enterocyte 
effacement), pathogenicity island which is important for 
adherence in the colon, (i.e. through the presence of the 
eae gene expressing the intimine protein). However, those 
E. coli strains that encode a Shiga toxin but do not contain 
the LEE pathogenicity island are designated as STEC [2-
3]. Two types of these toxins have been described: Shiga 
toxin 1 (Stx1), which differs from true Shiga toxin by one to 
seven amino acids, and Shiga toxin 2, (Stx2), which shares 
about 60% sequence homology with Stx1. These bacteria are 
therefore often called Shiga toxin-producing E. coli (STEC). 
Functionally-active Shiga toxins may be detected using 
the Vero cell toxicity test which is why bacteria producing 
these are also called verotoxin or verocytotoxin-producing 
E. coli (VTEC). These Shiga toxins may cause symptoms of 
uncomplicated diarrhoea through to HC that may progress 
into HUS, consisting of a micro-angiopathic haemolytic 
anaemia, thrombocytopenia, and severe acute renal failure 
requiring intensive care [5]. Shiga-toxin genes are coded in 
lambda-type bacteriophages which are incorporated into the 
E. coli genome as lysogenes. These phages have the ability to 
infect pathogenic and non-pathogenic E. coli strains from 
the human intestine and are capable of producing Shiga-
toxins and infectious particles of bacteriophages, which 
may enable the toxin genes to be spread among other E. coli 
strains (lytic cycle). This, therefore, is the reason why the best 
way to identify EHEC strains are genetic tests based on the 
detection of Shiga-toxines genes [6].
epidemiology 
STEC have been recognised since the early 1980s as 
important food-borne pathogens [7] and the serogroup 
STEC/VTEC O157 was the first of its kind to be identified 
as a source of human disease; being responsible for a large 
number of reported outbreaks during recent decades [6]. 
STEC infection began to be a public health problem when 
it was first recognized in 1982 following an outbreak in the 
USA associated with undercooked hamburgers [2]. From 
1982–2002, a total of 350 E. coli O157 outbreaks were reported 
from 49 states in the USA, accounting for 8,598 cases of E. coli 
O157 infection consisting of 1,493 (17.4%) hospitalisations, 
354 (4.1%) cases of HUS, and 40 (0.5%) deaths. The number of 
reported outbreaks began rising in 1993, and peaked in 2000 
at 46, where food remained the predominant transmission 
route [8]. According to data from EFSA, the serogroup O157 
has been the most commonly detected serogroup in recent 
years in Europe, representing about 52% of the confirmed 
cases with known serotypes. Altogether, 16,263 confirmed 
human VTEC cases have been notified in EU Member States 
in the period 2005–2009, including two to six cases of death. 
STEC/VTEC O157 accounted for almost two-thirds (63.2%) 
of the 242 HUS cases [5]. O157 is also the most important 
EHEC serotype with respect to public health in North 
America, the United Kingdom, and Japan [2]. However, 
it has been observed recently that the disease in humans 
is also caused by other serotypes; the so called non-O157 
STEC, where the full spectrum of pathogenic non-O157 
serogroups and the illnesses they cause remain poorly defined 
[9]. Evaluation of non-O157 STEC isolates from subjects in 
the United States found that 6 of the 61 serogroups identified, 
(i.e. O26, O111, O103, O121, O45, and O145), accounted for 
71% of the isolates recovered from 1983–2002, whereas three 
of these serogroups, (O26, O111, and O103), accounted for 
50% of the isolates. The non-O157 STEC demonstrated peaks 
in summertime similar to that for the STEC O157:H7, and 
were isolated more frequently from children [10]. Apart from 
classical EHEC, the newly emerging enteroaggregative EHEC 
O104:H4 strain was identified as the causative agent in a large 
outbreak of HC and HUS in Germany and other European 
countries which occurred in May and July of 2011 [9, 11]. 
Sporadic cases of Shiga-toxin gene E. coli serotype O104:H4 
carriers have been reported before, and nine cases of 
STEC O104 infection were reported in the EU Member States 
during 2004–2009, with single cases occurring in France 
(2004), Belgium and Denmark (2008), and in Austria, Finland 
and Sweden (2010), as well as Norway having one case in 2006 
and 3 in 2009. 56% of these cases were male, with ages ranging 
from < 1 year to 76 years. One of the cases (11%) developed 
HUS and four (44%) were travel-related; the countries of origin 
being Afghanistan (2008), Turkey (2009), Egypt and Tunisia 
(2010). Only two of the STEC O104 cases were of serotype 
STEC O104:H4 – in France (2004) and Finland (2010). The 
latter case was travel-related with infection acquired in Egypt 
[5, 12, 13]. STEC O104:H4 has also been isolated twice in 
Germany (2001) [14] and once in Korea (2005) [15]. 
As previously mentioned, in May and July 2011, a major 
outbreak of gastroenteritis with bloody diarrhea and 
HUS related to infections with STEC O104:H4 was reported 
[12]. Most of these were among residents in Germany (96.5%) 
and travellers to northern Germany from other countries. 
Additional cases were also reported from Switzerland, 
USA and Canada [16]. In Poland, two confirmed cases 
of STEC O104:H4 occurred in a household outbreak, (in 
Gizycko). Two clinical samples collected from a 7-year-old 
boy with HUS and his nanny were observed to have the same 
unique virulence properties as the STEC O104:H4 strain 
from the international outbreak. Retrospective serological 
investigations proved person-to-person transmission of 
the STEC O104:H4 strain originating from the boy’s father 
who had previously visited Dortmund in Germany [17]. 
This outbreak was the first and largest of its kind in which 
25% of all laboratory-confirmed STEC O104:H4 serotype-
infected cases evolved into the HUS, while the others 
presented with STEC related gastroenteritis. The mortality 
rate was 3.3% in the former and 0.5% in the latter group 
[16]. The outbreak demonstrated three unusual features. 
Firstly, a large proportion of the patients suffered from 
HUS, (> 800 cases) [18, 19], and secondly, it was largely 
confined to adults (89%) of whom the majority were women 
(68%) [19], (although it usually affects children); and finally, 
frequent development of neurologic symptoms was observed 
in patients when clinical and laboratory indicators of HUS 
were improving [18]. It has been tentatively suggested that 
differences in antibiotic treatment regimens between adults 
and children may explain why the incidence of HUS was 
observed to be higher in the former, although further studies 
are ongoing to confirm this [20].
The likely source of contamination for this outbreak strain 
was found to be fenugreek sprouts and seeds; however, 
neither detection nor isolation of the E. coli O104:H4 has 
thus far been possible. This may be due to the known ability 
of bacteria, including the E. coli strain, to exist in a dormant 
state, (e.g. the viable but non-culturable VBNC state), where   
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outbreak strains were resistant to ampicillin, third generation 
cephalosporins, streptomycin, nalidixic acid, tetracycline, 
and co-trimoxazole, but were susceptible to carbapenems, 
ciprofloxacin, chloramphenicol, kanamycin, and gentamicin 
[32]. However, it is not known when the outbreak strain 
acquired the gene encoding CTX-M-15-type ESBL. To date, 
only two STEC strains with an ESBL-producing phenotype 
have been reported in the literature, a CTX-M-3-type ESBL-
producing STEC O26:H11 strain and CTX-M-18-type ESBL-
producing STEC O26:H11 strain; both in 2005 [16]. 
Summing up, E coli O104:H4 is Shiga toxin-positive (stx2a), 
intimin-negative (eae), enterohaemolysin-negative (hyl) 
and adheres to enteroaggregative E. coli (EaggEC). Thus, 
it possesses genetic characteristics that could explain its 
virulence, with an unusual combination of virulence factors, 
being both shigatoxin-producing and enteroaggregative 
[1, 7]. The German outbreak strain harboured a unique 
combination of EHEC and EAEC genomic features. These 
data suggest a new E. coli pathotype EAHEC that has EHEC 
and EAEC ancestors [2]. In contrast to STEC/VTEC strains, 
which have an animal reservoir, mostly ruminants, EAggEC 
strains probably only have a human reservoir [33]. 
hAemolytiC uremiC syndrome – symptoms, 
pAthogenesis And treAtment 
HUS is characterised by the triad of acute renal 
failure, (with high urea and creatinine levels), haemolytic 
anaemia, (haemoglobin < 10 g/dL), with fragmented 
erythrocytes (schizocytes), and thrombocytopenia (platelets 
< 150,000/mm3). High lactate dehydrogenase (LDH) is also 
observed, often involving the central nervous system [31, 
34, 35, 36]. The median incubation period, (from exposure 
to the onset of diarrhoea), was 8 days, and the interval from 
the onset of diarrhea to the diagnosis of the HUS was 5 days. 
Bloody diarrhoea (80%) and abdominal pain (78%) were the 
most common symptoms observed in infected cases, whereas 
vomiting (19%) and low-grade fever (7%) were less frequently 
reported [16]. Pancreatic failure and cardiac involvement 
are less frequent during the acute phase of HUS (2%) [35]. 
Overall, the incidence of HUS in STEC infections is around 
6-9%, and 15% in children, whereas in the STEC-O104:H4 
outbreak it rose to 25% [37]. HUS-causing O104:H4 strains are 
more closely related to typical EAEC than to EHEC strains 
[38]. Unlike children, adults with HUS have high mortality 
rates; up to 86% in the elderly [39]. HUS is a complication of 
infection with Shiga-toxin-producing bacteria, although other 
infections, such as Salmonella enteritidis and Streptococcus 
pneumonia [35] and inheritable abnormalities in complement 
regulatory proteins can cause the disorder[40]. Despite its 
low mortality rate (5-7%), it is associated with significant 
morbidity; 50% of patients require extra-renal depurative 
techniques and 5-10% have renal sequelae [37].
The augmented adherence to intestinal epithelium might 
facilitate systemic absorption of Shiga toxin in infected cases, 
and explains the high frequency (25%) of progression to HUS, 
and the serious consequences after infection, e.g. organ damage 
and death [16]. After its adherence to enterocytes, STEC 
produces attaching-effacing lesions through its plasmidic 
encoded proteins [37]. Stx are composed of an enzymatically-
active A subunit and a pentameric B subunit. The B subunits 
form a doughnut-shaped structure with a central pore, and 
detection by culture-based methods may be possible only 
under very specific conditions [21].
More recently, in the autumn of 2011, a diarrheal illness 
cluster was detected in elderly female tourists in France 
(8/22 subjects), returning from Turkey. Two cases were 
of HUS caused by E. coli O104:H4, genetically similar to 
the German outbreak strain. The timing of the symptoms 
appearing together with the known incubation period make 
it highly likely that exposure occurred in Turkey, adding 
evidence that this E. coli serogroup circulates in this region 
of the world [22].
eheC o104:h4 strAin ChArACteristiCs  
And virulenCe
Some differences have been discovered in genetic 
construction between previously isolated EHEC strains and 
this last outbreak strain [1, 19]. Comparisons of genome 
sequences between two E. coli O104:H4 strains derived 
from the 2011 German EHEC outbreak in patients with 
other pathogenic E. coli strains suggests that the O104:H4 
strain represents a new E. coli pathotype, which has been 
named Entero-Aggregative-Haemorrhagic Escherichia coli 
(EAHEC). The analyses indicate that a number of horizontal 
gene transfer events took place to create the genome of the 
German outbreak strain [2].
The O104:H4 epidemic strain was found to have a 
genetic marker characteristic of enteroaggregative E. coli 
(EAEC) [18]; however, unusually, it lacked the attaching/
effacing pathogenicity island of virulent STEC strains. In 
this strain, scientist have also identified the presence of 
the receptor for iron-chelating aerobactin, known to be a 
virulence factor associated with the extra-intestinal E.coli 
pathotype (ExPEC) [23]. Because of the merged virulence 
profiles it has been postulated that the outbreak strain is 
a typical EAEC strain that acquired the bacteriophage 
encoding stx2 (Shiga toxin 2) [16, 24], with the capacity 
to colonise the human GI tract effectively in combination 
with the production of this virulent cytotoxin [25]. The 
strain also has a distinct set of virulence factors, including 
three regions encoding serine protease autotransporters of 
enterobacteriaceae (SPATEs), which promote colonisation, 
mucosal damage, and subsequent discharge of Stx into the 
circulation [26]. STEC O104:H4 harbours three plasmids, 
of which the two larger are of particular interest. The larger 
plasmid (ca. 88 kb), designated pESBL, contains the genes 
bla CTX-M-15 [type of β-lactamase (class A)] encoding 
extended-spectrum β-lactamase agar (ESBL) CTX-M-15 
and bla TEM-1 [type of β-lactamase (class A)] encoding 
TEM-1 β-lactamase [27, 28]. This plasmid encodes resistance 
of the strain to a broad spectrum of antimicrobials. The 
smaller plasmid (ca. 75 kb) contains virulence loci typical 
for EAEC, including aggR encoding master regulator of 
EAEC plasmid virulence genes, and several genes under 
transcription control of AggR. It also contains the aggABCD 
cluster, encoding aggregative adherence fimbriae I (AAF/I), 
which mediate the characteristic aggregative adherence of 
this strain to intestinal epithelial cells [28, 29]. The eae gene, 
encoding adhesion intimin, (an intestinal adherence factor), 
astA, encoding enteroaggregative E. coli Shiga toxin 1 (Stx1) 
ehx (encoding enterohemolysin toxin) [30] and haemolysin 
A (hlyA) [27, 31], were not present. Isolates containing the   
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bind to the glycosphingolipid globotriaosylceramide (Gb3), 
which is expressed at the surface of endothelial cells, leading 
to subsequent internalization of the toxin. The A subunit is 
able to inhibit elongation of the peptide chain during protein 
synthesis, resulting in eukaryotic cell death, tissue damage 
and organ failure [30]. New findings suggest that STX also 
directly interferes with the alternative complement pathway, 
and it is this that forms the key pathogenic mechanism [37]. 
The histological lesions are characterised by thickening of 
arteriole and capillary walls, with swelling and detachment 
of the endothelial cells from the basement membrane and 
the accumulation of fluffy material in the subendothelium 
and intraluminally, together with increased platelet 
aggregation. Thrombi affect the microcirculation and in HUS 
microthrombi are present primarily in the kidneys, which 
often leads to renal complications [41]. Thrombocytopenia, 
(platelet count of <150,000 per mm3), is the first abnormality 
seen in STEC infections, whether the patient develops HUS 
or not, and lasts up to one week [30]. Microangiopathic 
haemolytic anaemia is a result of a traumatic rupture due to 
endothelial thrombi and is the most persistent abnormality, 
usually preceding renal failure [37]. The renal involvement 
ranges from haematuria, (usually microscopic), and 
proteinuria, to severe renal failure and oliguria that occur 
in 50% of cases. Hypertension is common [42]. Dialysis is 
initiated to correct metabolic abnormalities when required. 
The short-term renal prognosis is generally favourable. 
However, the risk of renal failure 20 years after recovery from 
Stx-HUS is not insignificant, and renal histology showing a 
glomerular microangiopathy affecting > 50% of glomeruli, 
arterial microangiopathy, and/or cortical necrosis is the 
best indicator of long-term prognosis [43]. Moreover, the 
simultaneous involvement of other microvascular beds, to 
greater or lesser extents, in the heart, brain and pancreas, is 
recognised and has been reported in all subtypes of HUS [44]. 
The neurological symptoms ranged from mild disorientation 
to qualitative and quantitative alterations of consciousness 
[45]. CNS pathology associated with HUS includes seizures, 
encephalopathy and brain infarction [46], and may also affect 
cortico-subcortical areas and in so doing determines motor 
and neurocognitive outcomes, thus decreasing the patients’ 
quality of life [35]. Neurological symptoms are observed, such 
as irritability, drowsiness, cortical blindness, hemiparesis or 
coma [47], double vision, dysphasia, hyperreflexia and apraxia, 
to the loss of adverse effects reflexes or repeated epileptic 
seizures requiring intubation and mechanical ventilation 
[45]. These symptoms may be a consequence of thrombotic 
occlusions, (coagulative necrosis due to microthrombosis 
without haemorrhage), microangiopathic changes of small 
vessels, (oedema and focal haemorrhage), direct injury from 
the toxin, ischaemia-reperfusion injury, hypertension and 
metabolic dysregulation, (e.g. hypoglycaemia, dehydration, 
acid-base disturbances, changes in serum osmolarity or 
azothemia) [37]. Neurologic evaluation at the acute phase 
and during follow-up is crucial to diagnose CNS damage 
and prevent medium- and long-term sequelae [35].
treAtment
Most people recover without any specific treatment 
in 5–10 days. The WHO recommends that in general, 
treatment of HUS with antibiotics and antidiarrhoeals is 
not recommended for patients infected with EHEC. Such 
treatments have been reported to actually increase the 
likelihood of complications. The WHO recommends people 
who are experiencing the characteristic symptoms to seek 
medical attention and not self-medicate. For patients with 
severe HUS, blood transfusions and dialysis might be needed 
to support failing kidneys [1]. Optimum therapy for HUS 
is still controversial [48]. This syndrome, together with the 
further effects of toxin and complement complex formation, 
must be managed and addressed urgently by using a multi-
targeted approach [49]. HUS treatment is based on hydro-
electrolytic management, peripheral and central venous 
pressure must be monitored, and cardiac function closely 
controlled; renal function control is especially important, as 
well as caloric intake adjustment [35]. HUS with severe renal 
insufficiency or brain impairment, and for atypical HUS is 
mostly treated by plasma therapy which involves the addition 
of fresh plasma to newborns, (plasmapheresis or plasma 
exchange is carried out). This removes the antibodies in the 
blood which damage the ADAMTS13 enzyme [50]. Several 
mechanisms might account for the effectiveness of plasma 
exchange, including early toxin removal from the circulation 
[51]. Some claim that antibiotic treatment of children with 
STEC has been associated with an increased risk of overt HUS 
[52]. Antibiotic-induced injury to the bacterial membrane 
might favour the acute release of large amounts of preformed 
toxin. If antibiotic therapy is deemed clinically appropriate, 
carbapenems should probably be regarded as a first treatment 
choice [48]. Several randomised and controlled trials have 
been carried out in children with HUS where the findings 
showed that none of the interventions, including transfusion 
of fresh frozen plasma, administering heparin, Shiga toxin-
binding agents or steroids, was better than supportive therapy 
on its own for all-cause mortality outcome or long-term 
neurological or renal sequelae (panel). Another form of 
therapy under consideration is treatment with Eculizumab, 
an anti-C5 monoclonal antibody [53] component of the 
complement system, which inhibits the uncontrolled 
complement activation [45, 54]. Eculizumab binds to C5 
and prevents the generation of C5a and the formation of 
the membrane attack complex [43] that amplifies vascular 
damage on exposure to Shiga-toxin [51]. Eculizumab is also 
effective in atypical forms of HUS caused by underlying 
defects in complement regulation [26].
the epidemiologiCAl situAtion in germAny 
following the outbreAK of E. coli o104:h4 
ContAminAtion in food
On 26 May 2011, the German Rapid Alert System 
for Food and Feed (RASFF) issued a notification that 
Enterohaemorrhegic  E.  coli strains (EHEC) had been 
identified in four cucumber samples taken at the time when 
the countrywide incidence of HUS and STEC infections had 
been significantly increasing since 21 May. Studies at the 
Robert Koch Institute demonstrated that afflicted patients 
had eaten significantly more raw tomatoes, cucumbers and 
lettuce compared to healthy controls. As a result, the German 
Bundesinstitut für Risikobewertung (Federal Institute for 
Risk Assessment) publicly recommended that eating these 
vegetables should be avoided at the present time because 
they constitute a potential source of the pathogen, and that   
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more care is needed with hygiene procedures, especially in 
the northern parts of Germany [1]. 
Related instances of illness and infection were also noted 
in other countries of the EU, including Sweden, Denmark, 
Holland, UK, France, Austria, Poland, Spain, Luxemburg, 
Greece, Czech Republic and Norway. A document informing 
the public about how to avoid infection from the strain 
responsible for the German outbreak was prepared by the 
ECDC and EFSA; proper personal hygiene, (e.g. washing 
hands), before/after preparing food was stressed. The sources 
of contamination were at first traced to vegetables, and 
consequently a large number of such samples were analysed, 
(e.g. from patient’s homes, marketplaces, distribution 
centres, etc.). Nevertheless, the infection source could not be 
identified; a major difficulty being the long disease incubation 
period because patients were hospitalised 8-10 days after 
becoming infected [1, 2].
The first indications that the infection source could be 
sprouts, (in particular mixtures containing lentils, alfalfa 
seeds, fenugreek and adzuki beans), showed that it originated 
from organic cultivation in Bienenbüttel Gaertnerhof in 
Lower Saxony. These sprouts had been supplied to all catering 
facilities in which people who became sick had eaten and 
the relevant products were therefore withdrawn from the 
market. Despite intensive sampling of seeds, seedlings and 
from production equipment, analyses did not confirm the 
presence of STEC/VTEC bacteria. During this time, the 
number of new cases recorded decreased [5, 20].
The German authorities, however, did not rescind their 
recommendations for restricting consumption of vegetables 
as the possibility of second wave infections might be 
expected. Further sampling and analyses were performed 
which included several hundred samples of products, raw 
materials and environmental samples from a manufacturer 
in Lower Saxony, where account was taken of the location 
of production, water supply and sewage disposal. Sprouts 
from other manufacturers were also investigated. However, 
after analysing the 853 samples taken to this time, no EHEC 
bacteria had been detected. Nevertheless, after analysing 
supply routes, patient feedback, and observing where new 
cases had occurred, the indications were that the EHEC 
infection has spread from a particular farm in Lower Saxony 
where in many cases the distribution of seedlings and seeds 
matched the geographical pattern. Finally, on 11 June 2011, 
the German authorities reported that a strain of EHEC 0104: 
H4 Had been identified in samples taken from the seedling 
household waste of one of the families in which two members 
were diagnosed with EHEC 0104: H4. The first analysis of 
these samples was performed by a laboratory in Krefeld 
and demonstrated the presence of EHEC 0104: H4. The 
result was subsequently confirmed by the National Reference 
Laboratory at the Federal Institute for Risk Assessment. The 
German authorities also notified that the sprouts had come 
from an organic farm in Bienenbüttel Gaertnerhof in Lower 
Saxony [1, 2, 5].
the epidemiologiCAl situAtion  
in frAnCe following the outbreAK  
of E. coli o104:h4 ContAminAtion in food
On 24 June 2011, the French authorities informed that 
EHEC O104: H4 cases had been detected and confirmed, 
consisting of two cases of infection with E. coli producing 
Shiga toxin (STEC), 9 cases of HUS, and four cases where 
HUS was not suspected. Eleven of the patients had attended 
the same event in the district of Bordeaux. Infection caused 
by strain O104: H4 was confirmed in 12 out of 15 cases. 
Epidemiological investigations showed that the potential 
source of infection were from fenugreek seed sprouts. 
Phenotypic and genotypic characteristics of E. coli O104: H4 
isolates obtained from French and German cases were 
found to be similar. The French authorities immediately 
began tracing the distribution pathways of sprouts and 
seeds suspected of causing the disease where a British 
company was identified as being the supplier. Thanks to 
the efforts of British Food Control bodies, the UK authorities 
established that the organic fenugreek seeds had originally 
been purchased in Germany, from the importer who had 
imported seeds from Egypt, and who had also delivered 
these seeds to the other EU member countries. One of the 
German distributors to customers in the EU was found to 
have supplied the infected product to Poland, the recipient 
being a company from the Małopolska Province. The 
District Sanitary Inspection in Kraków then attempted 
to establish the distribution list of fenugreek seeds and 
mixtures in Poland. As a result, 16 packages of grains 
containing fenugreek were immediately withdrawn from 
the market. It was not possible, however, to identify all 
the individual customers who had previously bought these 
products. Nonwithstanding, those found by the SSI to have 
consumed the seeds showed no signs of illness. Furthermore, 
subsequent analyses by the SSI of the withdrawn packages of 
fenugreek seeds and seed mixtures did not show the presence 
of a strain of E. coli O104: H4. Despite this, the withdrawn 
products were destroyed in accordance with Commission 
Decision (2011/402/UE) [13].
the position of the eC regArding  
the outbreAKs in germAny And frAnCe
Laboratory analysis of samples from infected people 
performed by EC, EFSA, ECDC and the WHO traced 
the most likely common source to a batch of fenugreek 
seeds imported from Egypt. As a result, the EC Bureau of 
Food and Veterinary Office conducted an audit in Egypt 
for possible confirmation. Certain shortcomings were 
identified in the manufacturing process, where E. coli O104: 
H4 contamination of the seeds may have arisen through 
contact with human or animal faeces. Such problems 
were not observed in the production of fresh vegetables 
or legumes intended for human consumption. Thus, the 
threat to food security was considered to be confined only 
to the sprouting fenugreek seeds, and the re-importation of 
other produce could be permitted. The Polish State Sanitary 
Inspectorate undertook national checks with the producers 
and distributors of the seeds intended for sprout manufacture 
on the Polish market, and it was determined that most had 
originated from domestic sources. The rest came either 
from other EU countries, i.e. Italy, Germany, UK, or from 
third countries, China, USA, Mexico, Canada, Turkey, Peru, 
Argentina, India and Thailand. There were none directly 
from Egypt [1, 13, 16].  
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the situAtion in polAnd – ACtions  
by the stAte sAnitAry inspeCtorAte (ssi)
Following instructions from the Chief Sanitary 
Inspectorate in Poland at the end of May 2011, the SSI 
began additional monitoring due to concerns over the 
possibility of infection/illness cases appearing in Poland, 
originating from abroad, where increased incidences of HUS 
caused by verotoxin, (from STEC) had been detected from 
the outbreaks in Germany and France, as well as cases in 
other EU countries. Microbiological analysis was therefore 
undertaken on numerous samples of fruit and vegetables, 
particularly imported cucumbers from Spain, (Almeria 
and Malaga provinces), and Germany. Domestic samples 
were also analysed from fresh produce sold primarily in 
hypermarkets, supermarkets, local markets and fruit and 
vegetable markets, which included cucumbers, tomatoes, 
spinach, radishes, lettuce, carrots, endive salad, cabbage 
and sprouts, as well as chopped and whole ready-to-eat 
vegetables. Particular attention was paid to organic farm 
produce. Weekly sampling of five samples/vegetable type was 
performed in each province – a total of 720. Subsequently, 
the intense checking of produce from Spain was stopped 
as the threat was then perceived to be negligible; however, 
extra vigilance was maintained for all produce coming from 
Germany, irrespective of the country of ultimate origin. 
Samples were tested according to EC regulations. A critical 
value of an increase in >10cfu/g of single-turquoise colonies on 
agar plates with TBX medium was set to merit further detailed 
molecular analyses in order to exclude the verotoxigenic 
strain of E. coli. This low value being a reflection of the fact 
that a low dose of serotype O104: H4 is highly infective, 
(<1,000 cells), thus a small number of pathogens can cause 
serious illness in people. All further work on identification 
was performed at the National Veterinary Institute – National 
Research Institute in Puławy in accordance with decisions by 
the Chief Sanitary Inspector and the Minister of Agriculture 
and Rural Development. Control measures were targeted 
at the sources used for on sale products or those used in 
the production or processing of fresh fruit and vegetables. 
Product traceability systems were also checked for suppliers 
and customers, the conditions of transporting and storage 
of fresh fruits and vegetables, as well as the correctness of 
technological processes in which fruits and vegetables are to 
be used as raw material. In addition, checks were made to see 
whether Good Manufacturing Practice had been followed 
and whether the principles of hygiene in sales/production 
had been adopted; including staff personal hygiene and how 
they have been incorporated into established Principles of 
Good Hygiene Practice in factories.
Information and education campaigns were instigated 
aimed at raising awareness of the potential sources of threat, 
how food should be safely prepared for consumption and 
maintenance of good personal hygiene. Departments 
responsible for this sanitary supervision were Food 
Hygiene, Nutrition and Consumers, Epidemiology, Health 
Education and Health Promotion, and Health of Children 
and Youth. Advice was provided to commercial facilities 
and caterers during inspection, (including distributing 
educational material), on how best to reduce or avoid 
infection in the consumption of fresh fruit and vegetables. 
In similar fashion, the general public were also informed 
and educated. Recommendations on basic hygiene practice 
and exercising care when preparing/consuming imported 
fresh fruit and vegetables for the general public were made 
available on the websites of the Chief Sanitary Inspectorate, 
Provincial Sanitary-Epidemiological Stations and selected 
Sanitary-Epidemiological Stations. Travellers and visitors 
from Germany were likewise targeted as were physicians/
GPs who were sent relevant information on verotoxigenic 
Escherichia coli. The websites contained a leaflet ‘Five Steps to 
Food Safety’ which was also distributed in public buildings, 
city and municipal offices, food/nutritional establishments 
handling food and especially to mass catering facilities, 
including small restaurants, food outlets in market stalls, 
and on tourist routes – in railway and bus stations and all 
other public places, as appropriate.
the reporting of results in polAnd
The National Focal Point of the SSI provided daily, 
detailed reports on the number of inspections undertaken, 
(specifying vegetable type and country of origin), and results 
from laboratory analyses to the RASFF system, (Rapid Alert 
System for Food and Feed), and the EWRS, (Early Warning 
and Response System). Information on developments in 
Germany was also received by the former.
On 2 June 2011, the Russian Federation (RF) introduced 
a ban on imports of vegetables from EU member states. 
Subsequently this was revised on 22 June in Moscow where 
the EU and RF concluded an agreement to restore the export 
of vegetables to the RF, on the condition that EU member 
countries attach export certificates to all shipments that the 
vegetables are free of the E. coli O104: H4 bacteria. In Poland, 
the competent authority empowered with issuing such 
certificates was the State Plant Health and Seed Inspectorate; 
however, the certification solution proved to be short-lived 
following the 26 July 2011 announcement made by the Robert 
Koch Institute in Berlin that the epidemic outbreak of E. coli 
O104 infection: H4 STEC in Germany had stopped. The RF 
then dropped its certification requirement. In Poland, this 
applied from 10 August 2011, when the SSI ceased performing 
the additional checks/tests.
These checking procedures nevertheless demonstrated 
that the majority of plants, fruit and vegetables used for 
consumption/cooking were domestic products delivered by 
local suppliers or farmers. In all, during the period 31 May 
2011 – 10 August 2011 the SSI carried out 24,550 inspections 
which consisted of collecting 2,872 samples of fresh fruit 
and vegetables because of the E. coli outbreak, including 670 
samples from Germany, Spain and Poland and 2,202 due to 
the aforementioned temporary RF requirements. There were 
however no cases in which the verotoxic strain of E. coli 0104 
had been identified.
Future sampling plans for 2012 will now entail 
taking 800 vegetable samples to test for the presence of 
enterohaemorrhagic E. coli O157 and the verotoxigenic E. coli 
O104 H4 serotype which is stipulated to be mostly from lettuce, 
cucumbers, spinach and carrots, as well as 800 samples of 
sprouts and seeds. This was prepared by the National Institute 
of Public Health – National Institute of Hygiene as part of 
the ‘Sampling Plan’ in the official food control system of 
monitoring by the SSI and performed according to current 
recommendations of the EFSA Biohazard Panel. These point 
out that monitoring of microbial contamination of the food   
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should not be limited to testing for the presence of the O157 
serotype, but should be extended to other types, such as 
verotoxigenic O104, O91, O103 in keeping with current 
knowledge. All Provincial Sanitary Inspectorates are to be 
responsible for collecting and pre-testing vegetable samples 
prior to testing for enterohaemorrhagic E. coli.
in ConClusion
Infectious diseases emerging throughout history have 
included some of the most feared plagues of the past. New 
infections continue to emerge today, while many of the old 
plagues are with us still. These are global problems. Emerging 
infectious diseases can be defined as infections that have 
newly appeared in a population or have existed but are rapidly 
increasing in incidence or geographic range. Among recent 
examples are hantavirus pulmonary syndrome [55, 56], Lyme 
disease [57, 58, 59, 60] and hemolytic uremic syndrome [22,   
61] caused by certain strains of Escherichia coli (eg. serotype 
O104:H4). Specific factors precipitating disease emergence can 
be identified in virtually all cases. These include ecological, 
environmental or demographic factors that place people at 
increased contact with a previously unfamiliar microbe or 
its natural host or promote dissemination. These factors 
are increasing in prevalence; this increase, together with 
the ongoing evolution of viral and microbial variants and 
selection for drug resistance, suggests that infections will 
continue to emerge and probably increase and emphasizes 
the urgent need for effective surveillance and control.
Effective control over such outbreaks is therefore a vital 
public health task. Early and rapid detection are necessary, 
including molecularly elucidating the pathogen. Identifying 
the contagion mode also needs to be fast, as does actions to 
limit the outbreak once it occurs, i.e. removal of the offending 
food product(s) from market circulation and ensuring the 
public is well informed, as well as measures preventing 
secondary spread, e.g. focusing on asymptomatic carriers. 
The recent spate of outbreaks also affords an opportunity to 
improve upon/design therapies for treating the STEC disease 
during its stages, including biomarkers of risk which may 
indicate the severity of the disease. Targets for antimicrobial 
therapy could include Stx phage induction, Shiga toxin 
production, virulence and resistance gene transfer, intestinal 
adherence, among others [62]. In addition, an appropriate 
surveillance strategy is essential, coupled with the most 
effective detection methods where developments in molecular 
subtyping should be exploited in the future.
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